Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5RAV7

Entry ID Method Resolution Chain Position Source
AF-Q5RAV7-F1 Predicted AlphaFoldDB

2 variants for Q5RAV7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs174321575 49 R>S No Ensembl
rs174321526 297 A>V No Ensembl

No associated diseases with Q5RAV7

2 regional properties for Q5RAV7

Type Name Position InterPro Accession
domain CARD domain 343 - 426 IPR001315
domain FIIND domain 51 - 336 IPR025307

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
NLRP3 inflammasome complex An inflammasome complex that consists of three components, NLRP3 (NALP3), PYCARD and caspase-1. It is activated upon exposure to whole pathogens, as well as a number of structurally diverse pathogen- and danger-associated molecular patterns (PAMPs and DAMPs) and environmental irritants. Whole pathogens demonstrated to activate the NLRP3 inflammasome complex include the fungi Candida albicans and Saccharomyces cerevisiae, bacteria that produce pore-forming toxins, including Listeria monocytogenes and Staphylococcus aureus, and viruses such as Sendai virus, adenovirus, and influenza virus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
peptidase activity Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.

5 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
inflammatory response The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
proteolysis The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MGIPTSSVSE EQESSEGQDS GDICSEENQI VSSYASKVCF EIEQDYKNRQ FLGPEGNVDV
70 80 90 100 110 120
ELIDKSTNTY SVRFPTAGWY LWPATGLGFL VRDVVTLTIG FGSWNQHLAL DLQHHEQWLV
130 140 150 160 170 180
GGPLFDITAE PEEAVAEIHL PHFISLQAGE VDVSWFLIAH FKNEGMVLEH PARVEPFYAV
190 200 210 220 230 240
LEKPSFSLMG ILLRIASGTR LSIPITSNTL IYYHPHPEDI KFHLYLVPSD ALLTKMIDDE
250 260 270 280 290 300
EDRFCGVRLQ TSPPVEPLNF GARYIVSNSA HLEIIPTELK LSYRSPGEIQ HFSKFYAGQM
310 320 330 340 350 360
KEPIQLEITE KRHETLVWKT VVKPVDIQLG AASAPPAFSG AAFVKENHRQ LQARMGDLKG
370 380 390 400 410 420
VLDDLQDNEV LTENEKELVE QAKTRQSKND TLLTMVEKKG DRALELLFRS ISERDPYLVS
YLRQQSL